Company: LHI
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006939
Chunk: 47

Company: Living Homeopathy International Ltd.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 47
---
 52% of our total voting power of our outstanding Ordinary Shares, and through Qingtian
Holdings Ltd, is beneficially interested in 2,340,000 Class A Ordinary Shares and 480,000 Class B Ordinary Shares, representing approximately
39.75% of our total voting power. Immediately after the completion of the offering, our directors and officers and Class B shareholders
will collectively control an aggregate of [*] % of the total voting power of our outstanding Ordinary Shares, Mr. To will be beneficially
interested in an aggregate of [*] % of the total voting power of our outstanding Ordinary Shares, immediately after the completion of
this offering, assuming the underwriters do not exercise their over-allotment option, our Class B shareholders, consisting of LTO Holdings
Ltd, wholly owned by Mr. To, . and Qingtian Holdings Ltd will own an aggregate of [●]% of our total voting power of our outstanding
Ordinary Shares. Assuming the two Class B shareholders continue to hold 7,020,000 Class A Ordinary Shares and 1,000,000 Class B Ordinary
Shares, so long as the total ordinary shares hold by the two Class B shareholders represent more than 26.7% of our total outstanding
ordinary shares, the two Class B shareholders, if vote together, will continue to control the outcome of matters submitted to shareholders
for approval. In cases where their interests are aligned and they vote together, our directors and officers who are beneficial owners
and the Class B Shareholders could have significant influence on determining the outcome of any corporate transaction or other matter
submitted to the shareholders for approval, including mergers, consolidations, the election of directors and other significant corporate
actions. In cases where their interests are aligned and they vote together, they will also have the power to prevent or cause a change
in control. Without the consent of some or all of these shareholders, we may be prevented from entering into transactions that could
be beneficial to us or our minority shareholders. The interests of these beneficial owners may differ from the interests of our
other shareholders. The concentration in the ownership of our Ordinary Shares may cause a material decline in the value of our Class
A Ordinary Shares. For more information regarding our beneficial owners and their affiliated entities, see “Principal Shareholders”
on page 101 of this prospectus.

You may face difficulties in protecting your interests, and your ability to protect your rights through U.S. courts may be limited, because we are incorporated under Cayman